NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 351 filers reported holding NOVAVAX INC in Q4 2020. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $100 | +163.2% | 7,873 | 0.0% | 0.00% | – |
Q1 2024 | $38 | 0.0% | 7,873 | 0.0% | 0.00% | – |
Q4 2023 | $38 | -83.7% | 7,873 | -51.4% | 0.00% | -100.0% |
Q3 2023 | $233 | +301.7% | 16,193 | +105.7% | 0.00% | – |
Q2 2023 | $58 | +5.5% | 7,873 | 0.0% | 0.00% | – |
Q1 2023 | $55 | -32.1% | 7,873 | 0.0% | 0.00% | – |
Q4 2022 | $81 | -99.9% | 7,873 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $143,000 | -64.7% | 7,873 | 0.0% | 0.00% | -50.0% |
Q2 2022 | $405,000 | -30.2% | 7,873 | 0.0% | 0.00% | -33.3% |
Q1 2022 | $580,000 | -48.5% | 7,873 | 0.0% | 0.00% | -40.0% |
Q4 2021 | $1,126,000 | -31.0% | 7,873 | 0.0% | 0.01% | -28.6% |
Q3 2021 | $1,632,000 | -2.4% | 7,873 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $1,672,000 | +17.2% | 7,873 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $1,427,000 | +62.5% | 7,873 | 0.0% | 0.01% | +75.0% |
Q4 2020 | $878,000 | +2.9% | 7,873 | 0.0% | 0.00% | -20.0% |
Q3 2020 | $853,000 | +30.0% | 7,873 | 0.0% | 0.01% | +25.0% |
Q2 2020 | $656,000 | – | 7,873 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 3,002,087 | $544,308,000 | 8.21% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 323,517 | $58,657,000 | 7.86% |
Samsara BioCapital, LLC | 198,600 | $36,008,000 | 6.64% |
Foresite Capital Management I, LLC | 66,810 | $12,113,000 | 6.11% |
Foresite Capital Management II, LLC | 67,373 | $12,215,000 | 2.81% |
SECTORAL ASSET MANAGEMENT INC | 191,200 | $34,666,000 | 2.63% |
Rock Springs Capital Management LP | 461,000 | $83,584,000 | 1.82% |
TSP Capital Management Group, LLC | 23,525 | $4,265,000 | 1.50% |
Ikarian Capital, LLC | 195,700 | $35,483,000 | 1.19% |
SevenOneSeven Capital Management | 1,744 | $316,000 | 1.16% |